LRRK2 and Parkinson disease: Of the PPMI participants with a clinical diagnosis of PD, 88% were S+ including 100% of SNCA PD, 93% of sporadic PD and GBA PD, 64% of LRRK2 PD, and 33% of PRKN PD.